Affiliation:
1. Department of Neurology Mayo Clinic Florida Jacksonville FL USA
2. Department of Psychiatry and Psychology Mayo Clinic Florida Jacksonville FL USA
3. Department of Quantitative Health Sciences Mayo Clinic Florida Jacksonville FL USA
4. Department of Neurology Washington University in St Louis St Louis MO USA
5. Division of Community Internal Medicine Mayo Clinic Florida Jacksonville FL USA
6. Mayo Center for Health Equity and Community Engaged Research Jacksonville FL USA
Abstract
ObjectiveThis study was undertaken to evaluate the frequency of modifiable dementia risk factors and their association with cognitive impairment and rate of decline in diverse participants engaged in studies of memory and aging.MethodsModifiable dementia risk factors and their associations with cognitive impairment and cognitive decline were determined in community‐dwelling African American (AA; n = 261) and non‐Hispanic White (nHW; n = 193) participants who completed ≥2 visits at the Mayo Clinic Alzheimer Disease Research Center in Jacksonville, Florida. Risk factors and their associations with cognitive impairment (global Clinical Dementia Rating [CDR] ≥ 0.5) and rates of decline (CDR Sum of Boxes) in impaired participants were compared in AA and nHW participants, controlling for demographics, APOE ɛ4 status, and Area Deprivation Index.ResultsHypertension, hypercholesterolemia, obesity, and diabetes were overrepresented in AA participants, but were not associated with cognitive impairment. Depression was associated with increased odds of cognitive impairment in AA (odds ratio [OR] = 4.30, 95% confidence interval [CI] = 2.13–8.67) and nHW participants (OR = 2.79, 95% CI = 1.21–6.44) but uniquely associated with faster decline in AA participants (β = 1.71, 95% CI = 0.69–2.73, p = 0.001). Fewer AA participants reported antidepressant use (9/49, 18%) than nHW counterparts (57/78, 73%, p < 0.001). Vitamin B12 deficiency was also associated with an increased rate of cognitive decline in AA participants (β = 2.65, 95% CI = 0.38–4.91, p = 0.023).InterpretationModifiable dementia risk factors are common in AA and nHW participants, representing important risk mitigation targets. Depression was associated with dementia in AA and nHW participants, and with accelerated declines in cognitive function in AA participants. Optimizing depression screening and treatment may improve cognitive trajectories and outcomes in AA participants. ANN NEUROL 2024
Subject
Neurology (clinical),Neurology
Reference50 articles.
1. United States Census Bureau.National Projections Tables 2017. Available from:https://www.census.gov/data/tables/2017/demo/popproj/2017-summary-tables.html.
2. Population estimate of people with clinical Alzheimer's disease and mild cognitive impairment in the United States (2020–2060)
3. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission
4. Alzheimer's Association.Alzheimer's facts and figures 2022. Available from:https://www.alz.org/alzheimers-dementia/facts-figures.